Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis In the Treatment of Abdominal Aortic Aneurysms

Active, not recruitingOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

January 31, 2026

Conditions
Abdominal Aortic Aneurysm (AAA)
Interventions
PROCEDURE

endovascular repair of the AAA

The Investigator will ensure that investigational devices are used only in subjects properly enrolled in the clinical study in accordance with the protocol. Subjects will undergo endovascular repair of their AAA. Procedural details may vary between sites, but will follow standard hospital protocol for EVAR and patient care management.

Trial Locations (8)

Unknown

APHP Hopital Européen, Paris

San Martino Hospital, Genova

Rijnstate Hospital, Arnhem

ETZ, Tilburg

San Carlos Hospital, Madrid

Complexo Hospitalario de Orense, Ourense

North Bristol NHS Trust, Bristol

5623EJ

Catharina Hospital, Eindhoven

All Listed Sponsors
lead

Marc van Sambeek

OTHER

NCT03743142 - Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis In the Treatment of Abdominal Aortic Aneurysms | Biotech Hunter | Biotech Hunter